Document Classification

Section Type: RESULTS

Text: After 48 months, the primary outcome of mean spine bone mineral density increased by 183 % (95 % CI 149-218) in 27 women in the teriparatide to denosumab group, 140 % (109-172) in 27 women the denosumab to teriparatide group, and 160 % (140-180) in 23 women in the combination to denosumab group, although this increase did not differ significantly between groups (for between-group comparisons, p = 013 for the teriparatide to denosumab group vs the denosumab to teriparatide group, p = 030 for the teriparatide to denosumab group vs the combination to denosumab group, and p = 041 for the denosumab to teriparatide group vs the combination to denosumab group).